Acne Wash Facial Cleanser Pink Grapefruit

Description

This product is an oil-free acne wash formulated with pink grapefruit as the active ingredient. It is designed to cleanse the skin while targeting acne-related concerns. The formulation is specifically developed to provide effective cleansing without the use of oils, making it suitable for various skin types.

Uses and Indications

This drug is indicated for the treatment of acne. There are no teratogenic effects associated with its use, and no nonteratogenic effects have been mentioned.

Dosage and Administration

Healthcare professionals are advised to instruct patients to wet their face prior to application. The product should be gently massaged onto the face for a duration of 20 to 30 seconds, ensuring that the eye area is avoided. Following the massage, it is essential to rinse the face thoroughly with water and then pat dry with a clean towel.

For optimal results, the cleansing process should be performed twice daily.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to adhere to the following precautions:

• Keep out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, seek medical assistance or contact a poison control center immediately.

• Avoid contact with eyes; if contact occurs, flush thoroughly with water.

Warnings and Precautions

For external use only; this product may cause staining on certain fabrics. Caution is advised when using this product in conjunction with other typical acne medications, as concurrent use may exacerbate skin dryness or irritation. In such cases, it is recommended that only one medication be utilized unless otherwise directed by a healthcare professional.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is advised without delay.

Patients are advised to discontinue use and consult their healthcare provider if any adverse reactions occur, although specific instructions for cessation were not provided in the available information.

Side Effects

Patients should be aware that this product is for external use only and may cause staining on certain fabrics.

In clinical practice, it has been observed that the concurrent use of this product with other typical acne medications, or the application of other products immediately following its use, may lead to increased dryness or irritation of the skin. In such cases, it is advisable to limit the use to one medication unless otherwise directed by a healthcare professional.

Drug Interactions

Concurrent use of this product with other typical acne medications may lead to an increased risk of skin dryness or irritation. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Wash Facial Cleanser Pink Grapefruit (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for this product. The use of salicylic acid is contraindicated in pregnant patients due to the potential risk to the fetus. Therefore, pregnant women should avoid using this product to mitigate any potential risks associated with fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient and to determine the most appropriate interventions.

Overall, vigilance and prompt action are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. If contact does occur, patients should be counseled to flush the eyes thoroughly with water to minimize any potential irritation or harm.

Storage and Handling

The product is supplied in a configuration that ensures safety and efficacy. It is essential to keep the product out of reach of children to prevent accidental ingestion or misuse.

In terms of handling, care should be taken to avoid contact with the eyes. In the event of accidental contact, it is advised to flush the affected area thoroughly with water. Proper storage conditions should be maintained to ensure the integrity of the product, although specific temperature ranges and container requirements are not provided.

Additional Clinical Information

The product is administered topically and should be applied after cleansing the affected area twice a day. Clinicians should advise patients to keep the product out of reach of children. In the event of accidental ingestion, patients are instructed to seek medical assistance or contact a poison control center immediately. Additionally, patients should avoid contact with the eyes; if contact occurs, they should flush the eyes thoroughly with water.

Drug Information (PDF)

This file contains official product information for Acne Wash Facial Cleanser Pink Grapefruit, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)